Hüseyin AYHAN, Telat KELEŞ, Bilge DURAN KARADUMAN, Engin BOZKURT

The triglyceride-glucose index predicts peripheral artery disease complexity

Background/aim: High levels of triglyceride (TG) and fasting blood glucose (FBG) values increase atherosclerosis risk. This study evaluates the relationship between peripheral artery disease (PAD) severity and complexity, as assessed by TransAtlantic InterSociety Consensus-II (TASC-II) classification and the triglyceride-glucose (TyG) index. Materials and methods: A total of 71 consecutive patients with PAD (males 93%, mean age 63.3 ± 9.7), who underwent percutaneous peripheral intervention were included retrospectively. The patients were divided into two groups according to the angiographically detected lesions. Those with TASC A-B lesions were included in Group 1, and those with TASC C-D lesions were included in Group 2. TyG index was calculated as formula: ln[fasting TG (mg/dL) × fasting plasma glucose (mg/dL)/2]. Results: There were 40 patients in Group 1 (90.3% men, with a mean age of 63.6 ± 9.3 years) and 31 patients in Group 2 (96.8% men, with a mean age of 62.0 ± 8.6 years). In the majority of patients in both groups, the target vessels are iliac arteries and femoral arteries. In Group 2, platelet count and TyG index were significantly high, according to Group 1. The TyG index was significantly correlated with TASC-II, Rutherford category, HbA1c, and HDL-C. Conclusion: In this present study, we showed that the TyG index was an independent predictor of peripheral artery disease complexity, according to TASC-II classification, for the first time in the literature.

PDF

___

1. Hardman RL, Jazaeri O, Yi J, Smith M, Gupta R. Overview of classification systems in peripheral artery disease. Seminars in Interventional Radiology 2014; 31 (4): 378-388. doi: 10.1055/s0034-1393976
2. Bartholomew JR, Olin JW. Pathophysiology of peripheral arterial disease and risk factors for its development. Cleveland Clinic Journal of Medicine 2006; 73: 8-14. doi: 10.3949/ ccjm.73.suppl_4.s8
3. Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127 (13): 1425- 1443. doi: 10.1161/CIR.0b013e31828b82aa
4. Megnien JL, Simon A, Gariepy J, Denarie N, Cocaul M et al. Preclinical changes of extracoronary arterial structures as indica- tors of coronary atherosclerosis in men. Journal of Hypertension 1998; 16 (2): 157-163. doi: 10.1097/00004872- 199816020-00005
5. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA et al. TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). European Journal of Vascular and Endovascular Surgery 2007; 45 (Suppl. 1): S5-S67. doi: 10.1016/j.ejvs.2006.09.024
6. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365 (9468): 1415-1428. doi: 10.1016/S0140- 6736(05)66378-7
7. Angoorani P, Heshmat R, Ejtahed HS, Motlagh ME, Ziaodini H et al. Validity of triglyceride-glucose index as an indicator for metabolic syndrome in children and adolescents: the CASPIAN-V study. Eating and Weight Disorders 2018; 23 (6): 877-883. doi: 10.1007/s40519-018-0488-z
8. Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. European Journal of Clinical Investigation 2016; 46 (2): 189-197. doi: 10.1111/ eci.12583
9. Sánchez-Iñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J et al. Risk of incident ischemic stroke according to the metabolic health and obesity states in the Vascular-Metabolic CUN cohort. International Journal of Stroke 2017; 12: 187-191. doi: 10.1177/17474 93016 67208 3
10. Irace C, Carallo C, Scavelli FB, De Franceschi MS, Esposito T et al. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. International Journal of Clinical Practice 2013; 67 (7): 665-672. doi: 10.1111/ijcp.12124
11. Da Silva A, Caldas APS, Hermsdorff HHM, Bersch-Ferreira ÂC, Torreglosa CR et al. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovascular Diabetology 2019; 18 (1): 89. doi: 10.1186/s12933-019-0893-2
12. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. Journal of Vascular Surgery 1997; 26 (3): 517-538. doi: 10.1016/s0741-5214(97)70045-4
13. Zhang M, Wang B, Liu Y, Sun X, Luo Xn et al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study. Cardiovascular Diabetology 2017; 16 (1): 30. doi: 10.1186/s12933-017-0514-x
14. Kim MK, Ahn CW, Kang S, Nam JS, Kim KR et al. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovascular Diabetology 2017; 16 (1): 108. doi: 10.1186/s12933-017-0589-4
15. Vega GL, Barlow CE, Grundy SM, Leonard D, DeFina LF. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. Journal of Investigative Medicine 2014; 62 (2): 345-349. doi: 10.2310/JIM.0000000000000044
16. Mao Q, Zhou D, Li Y, Wang Y, Xu SC et al. The triglycerideglucose index predicts coronary artery disease severity and cardiovascular outcomes in patients with non-st-segment elevation acute coronary syndrome. Disease Markers 2019; 2019: 6891537. doi: 10.1155/2019/6891537
17. Tanrıverdi B, Savaş Tetik Ş. Pathophysiology of theatherosclerosis and risk factors. Marmara Pharmaceutical Journal 2017; 21: 1-9 (in Turkish). doi: 10.12991-marupj.259875-226361
18. Lee SB, Ahn CW, Lee BK, Kang S, Nam JS et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovascular Diabetology 2018; 17 (1): 41. doi: 10.1186/s12933-018-0692-1
19. Budoff M. Triglycerides and triglyceride-rich lipoproteins in the causal pathway of cardiovascular disease. American Journal of Cardiology 2016; 118 (1): 138-145. doi: 10.1016/j. amjcard.2016.04.004
20. Tenenbaum A, Klempfner R, Fisman EZ. Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. Cardiovascular Diabetology 2014; 13: 159. doi: 10.1186/ s12933-014-0159-y
21. Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee. Catheterization and Cardiovascular Interventions 2015; 86 (4): 611-625. doi: 10.1002/ccd.26122
22. Kiyosue A. Nonfasting TG/HDL-C ratio seems a good predictor of MACE in CAD patients with statin therapy. Could it be a treatment target? Journal of Cardiology 2018; 71 (1): 8-9. doi: 10.1016/j.jjcc.2017.09.001
23. Mesut E, Cihan A, Orhan G. Is it possible to predict the complexity of peripheral artery disease with atherogenic index? Vascular 2020. doi: 10.1177/1708538120923531